Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.620
-0.360 (-7.23%)
At close: Aug 28, 2026, 4:00 PM EDT
4.700
+0.080 (1.73%)
After-hours: Aug 28, 2026, 7:49 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $482.64 million as of August 28, 2026. Its market cap has decreased by -21.61% in one year.
Market Cap
482.64M
Enterprise Value
363.48M
1-Year Change
-21.61%
Ranking
Category
Stock Price
$4.62
ChartMarket Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $482.64M, an increase of 189.00%. That is a compound annual growth rate of 20.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 444.90M | 103.34% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 562.46M |
| ProKidney | 547.20M |
| Kyverna Therapeutics | 541.13M |
| Entera Bio | 540.20M |
| Scribe Therapeutics | 528.58M |
| Editas Medicine | 516.80M |
| C4 Therapeutics | 512.40M |
| Evommune | 497.02M |